F
$ Value
$214K
Shares
12,787
Price
$17
Filed
May 27
Insider
Name
Keel Paul A
Title
Chief Executive Officer
CIK
0001626337
Roles
Director
Officer
Transaction Details
Transaction Date
2025-05-25
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
401,652
Footnotes
Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.
Filing Info
Keel Paul A's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-25 | NVST | F | $350K |
| 2026-02-25 | NVST | A | $0 |
| 2026-02-25 | NVST | A | $0 |
| 2026-02-25 | NVST | A | $0 |
| 2026-02-01 | NVST | A | $96K |
| 2025-11-01 | NVST | F | $1.1M |
| 2025-05-25 | NVST | F | $214K |
Other Insiders at NVST (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hammes Eric D.
Chief Financial Officer
|
— | — | 2026-02-25 |
|
Keel Paul A
Chief Executive Officer
|
— | — | 2026-02-25 |
|
Nance Mark E
General Counsel
|
— | — | 2026-02-25 |
|
Reis Mischa
SVP, Strategy & Bus. Dev.
|
— | $290K | 2026-02-25 |
|
Kaabi Faez C
Chief Accounting Officer
|
— | — | 2026-02-25 |
|
Befidi Robert
President, Diagnostics
|
— | — | 2026-02-25 |
|
Nilsson Stefan
President, Nobel Biocare
|
— | — | 2026-02-25 |
|
Acurio Veronica
President, Orthodontics
|
— | — | 2026-02-25 |